Exosomes Secreted by Endothelial Progenitor Cells Improve the Bioactivity of Pulmonary Microvascular Endothelial Cells Exposed to Hyperoxia

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2019 Jul 30

PMID 31355221

Citations 19

Authors

Xiaomei Zhang

Aizhen Lu

Zhi Li

Jiali Sun

Dan Dai

Liling Qian

Affiliations

Soon will be listed here.

Abstract

Background: Paracrine factors secreted by endothelial progenitor cells (EPCs) are suggested to be responsible, in part, for the improved microvascular development in bronchopulmonary dysplasia (BPD) models. This study aims to investigate the potential role of exosomes derived from EPCs (EPC-EXOs), a component of paracrine secretion, in angiogenesis by mediating the activity of PMVECs exposed to hyperoxia.

Methods: EPCs were isolated from bone marrow of rats. EPC-EXOs were isolated by ExoQuick-TC kits from the conditioned media of EPCs. The PMVECs were divided into three groups, including the normal group, the hyperoxia group (exposed to 85% O) and the EPC-EXOs treatment group (exposed to 85% O and EPC-EXOs with the concentration of 100 µg/mL). The activities of proliferation, migration and tube formation of PMVECs were detected at the endpoint. The mRNA and protein expression levels of VEGF, VEGFR2 and eNOS in different groups were detected by real-time quantitative PCR and western blot.

Results: We found EPC-EXOs exhibited a cup or biconcave morphology, with the size ranging from 30 to 150 nm, and positive for the characteristic exosomal surface marker proteins, CD63 and TSG101. Comparing to the control group, Hyperoxic stress impaired the proliferation, migration, and tubule formation of PMVECs, and decreased the expression of endothelial nitric oxide synthase (eNOS), vascular endothelial growth factor (VEGF), and vascular endothelial growth factor receptor 2 (VEGFR-2) of PMVECs. Comparing to the hyperoxia group, EPC-EXOs treatment enhanced the bioactivity of PMVECs , and increased the expression of eNOS, VEGF and VEGFR2.

Conclusions: Our data demonstrate EPCs secrete exosomes that have independent angiogenic activity . This may help explain in part the protective effects of EPCs on hyperoxic injury in the developing lung vasculature and may represent a promising therapeutic strategy for BPD.

Citing Articles

Research progress of microvascular development in bronchopulmonary dysplasia.

Zhang J, Du W, Zhang Z, Li T, Li X, Xi S Pediatr Investig. 2024; 8(4):299-312.

PMID: 39720284 PMC: 11664543. DOI: 10.1002/ped4.12441.

Purinergic P2X7 receptor mediates hyperoxia-induced injury in pulmonary microvascular endothelial cells via NLRP3-mediated pyroptotic pathway.

Zeng W, Deng Z, Li H, Gao S, Ju R Open Med (Wars). 2024; 19(1):20241097.

PMID: 39655049 PMC: 11627065. DOI: 10.1515/med-2024-1097.

Reinitiating lung development: a novel approach in the management of bronchopulmonary dysplasia.

Cui X, Fu J Respir Res. 2024; 25(1):384.

PMID: 39449014 PMC: 11515458. DOI: 10.1186/s12931-024-02996-8.

Clinical applications of stem cell-derived exosomes.

Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J Signal Transduct Target Ther. 2024; 9(1):17.

PMID: 38212307 PMC: 10784577. DOI: 10.1038/s41392-023-01704-0.

IRF4 affects the protective effect of regulatory T cells on the pulmonary vasculature of a bronchopulmonary dysplasia mouse model by regulating FOXP3.

Zhu Y, He L, Zhu Y, Yao H, Jiang J, Lu H Mol Med. 2024; 30(1):6.

PMID: 38195465 PMC: 10777489. DOI: 10.1186/s10020-023-00770-y.

References

Willam C, Schindler R, Frei U, Eckardt K . Increases in oxygen tension stimulate expression of ICAM-1 and VCAM-1 on human endothelial cells. Am J Physiol. 1999; 276(6):H2044-52. DOI: 10.1152/ajpheart.1999.276.6.H2044. View

Jobe A, Bancalari E . Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001; 163(7):1723-9. DOI: 10.1164/ajrccm.163.7.2011060. View

Bhatt A, Pryhuber G, Huyck H, Watkins R, Metlay L, Maniscalco W . Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001; 164(10 Pt 1):1971-80. DOI: 10.1164/ajrccm.164.10.2101140. View

Wagenaar G, Ter Horst S, van Gastelen M, Leijser L, Mauad T, van der Velden P . Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress. Free Radic Biol Med. 2004; 36(6):782-801. DOI: 10.1016/j.freeradbiomed.2003.12.007. View

Balasubramaniam V, Maxey A, Morgan D, Markham N, Abman S . Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia. Am J Physiol Lung Cell Mol Physiol. 2006; 291(1):L119-27. DOI: 10.1152/ajplung.00395.2005. View

Olsson A, Dimberg A, Kreuger J, Claesson-Welsh L . VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 2006; 7(5):359-71. DOI: 10.1038/nrm1911. View

Thebaud B, Abman S . Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med. 2007; 175(10):978-85. PMC: 2176086. DOI: 10.1164/rccm.200611-1660PP. View

Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee J, Lotvall J . Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9(6):654-9. DOI: 10.1038/ncb1596. View

Bland R, Mokres L, Ertsey R, Jacobson B, Jiang S, Rabinovitch M . Mechanical ventilation with 40% oxygen reduces pulmonary expression of genes that regulate lung development and impairs alveolar septation in newborn mice. Am J Physiol Lung Cell Mol Physiol. 2007; 293(5):L1099-110. DOI: 10.1152/ajplung.00217.2007. View

10.

Fracica P, KNAPP M, Piantadosi C, Takeda K, Fulkerson W, Coleman R . Responses of baboons to prolonged hyperoxia: physiology and qualitative pathology. J Appl Physiol (1985). 1991; 71(6):2352-62. DOI: 10.1152/jappl.1991.71.6.2352. View

11.

Edirisinghe I, Yang S, Yao H, Rajendrasozhan S, Caito S, Adenuga D . VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction. FASEB J. 2008; 22(7):2297-310. PMC: 4708085. DOI: 10.1096/fj.07-099481. View

12.

Di Santo S, Yang Z, Wyler von Ballmoos M, Voelzmann J, Diehm N, Baumgartner I . Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One. 2009; 4(5):e5643. PMC: 2682571. DOI: 10.1371/journal.pone.0005643. View

13.

Yee M, White R, Awad H, Bates W, McGrath-Morrow S, OReilly M . Neonatal hyperoxia causes pulmonary vascular disease and shortens life span in aging mice. Am J Pathol. 2011; 178(6):2601-10. PMC: 3124332. DOI: 10.1016/j.ajpath.2011.02.010. View

14.

Cantaluppi V, Gatti S, Medica D, Figliolini F, Bruno S, Deregibus M . Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 2012; 82(4):412-27. DOI: 10.1038/ki.2012.105. View

15.

Buczynski B, Maduekwe E, OReilly M . The role of hyperoxia in the pathogenesis of experimental BPD. Semin Perinatol. 2013; 37(2):69-78. PMC: 3627182. DOI: 10.1053/j.semperi.2013.01.002. View

16.

Madurga A, Mizikova I, Ruiz-Camp J, Morty R . Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2013; 305(12):L893-905. DOI: 10.1152/ajplung.00267.2013. View

17.

Wang J, Chen S, Ma X, Cheng C, Xiao X, Chen J . Effects of endothelial progenitor cell-derived microvesicles on hypoxia/reoxygenation-induced endothelial dysfunction and apoptosis. Oxid Med Cell Longev. 2013; 2013:572729. PMC: 3830832. DOI: 10.1155/2013/572729. View

18.

Gu S, Zhang W, Chen J, Ma R, Xiao X, Ma X . EPC-derived microvesicles protect cardiomyocytes from Ang II-induced hypertrophy and apoptosis. PLoS One. 2014; 9(1):e85396. PMC: 3879348. DOI: 10.1371/journal.pone.0085396. View

19.

Alphonse R, Vadivel A, Fung M, Shelley W, Critser P, Ionescu L . Existence, functional impairment, and lung repair potential of endothelial colony-forming cells in oxygen-induced arrested alveolar growth. Circulation. 2014; 129(21):2144-57. PMC: 4162516. DOI: 10.1161/CIRCULATIONAHA.114.009124. View

20.

Guaman M, Gien J, Baker C, Zhang H, Austin E, Collaco J . Point Prevalence, Clinical Characteristics, and Treatment Variation for Infants with Severe Bronchopulmonary Dysplasia. Am J Perinatol. 2015; 32(10):960-7. PMC: 4617756. DOI: 10.1055/s-0035-1547326. View